TMO vs VRTV: Which Is the Better Buy?
Side-by-side comparison of Thermo Fisher Scientific Inc. and Veritiv Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-06-20.
Thermo Fisher Scientific Inc. · Healthcare
$464.61
+7.2% upside to fair value
Grade A
High Quality
VS
Veritiv Corporation · Industrials
$169.99
-43.3% upside to fair value
Grade D
QuantHub Verdict
TMO has more upside to fair value
(+7.2%).
VRTV trades at a lower forward P/E
(7.1x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
TMO |
VRTV |
| Current Price |
$464.61 |
$169.99 |
| Fair Value Estimate |
$498.27 |
$96.38 |
| Upside to Fair Value |
+7.2%
|
-43.3%
|
| Market Cap |
$172.7B |
$2.3B |
| Forward P/E |
25.2x
|
7.1x
|
| EV / EBITDA |
19.1x
|
5.4x
|
| Price / Sales |
3.8x
|
0.3x
|
| Price / FCF |
25.6x
|
10.0x
|
| Revenue Growth YoY |
+6.2%
|
-19.0%
|
| Gross Margin |
39.4%
|
22.7%
|
| Operating Margin |
17.8%
|
5.9%
|
| Return on Equity |
13.3%
|
48.6%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
3.91%
|
9.99%
|
| Analyst Consensus |
Strong Buy
|
Hold
|
Investment Thesis
Thermo Fisher Scientific is a leading healthcare company specializing in life science tools, diagnostics, and contract research and manufacturing services. It operates with a broad, multi-layered moat driven by scale, integration, and a long-tenured management team. The company exhibits solid fundamentals with a 13.3% ROE, 6.2% revenue growth, and 9.6% earnings growth in the most recent quarter. …
Veritiv Corporation operates as a distributor primarily in packaging, facility solutions, and print markets, with a business quality characterized by scale and network density rather than proprietary products or pricing power. The company has undergone significant transformation under CEO Salvatore A. Abbate, including a take-private transaction by Clayton, Dubilier & Rice in 2023 and a strategic…
Accumulation Zones
| Metric |
TMO |
VRTV |
| Zone Low |
$373.70 |
$72.28 |
| Zone High |
$423.53 |
$81.92 |
| In Buy Zone? |
No
|
No
|